Kennedy-Wilson (KW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
17 Feb, 2026Executive summary
Entered into a merger agreement with a consortium led by Fairfax Financial Holdings, Bill McMorrow, and senior executives, announced on February 16, 2026.
Transaction expected to close in the second quarter of 2026, subject to customary closing conditions including stockholder and regulatory approvals.
Focus remains on business continuity and supporting employees, clients, and partners during the transition.
Forward-looking statements highlight risks such as failure to obtain approvals, disruption to operations, and potential litigation.
Voting matters and shareholder proposals
Stockholders will be asked to approve the merger at a special meeting; details to be provided in the Definitive Proxy Statement.
If the merger is completed, stockholders will no longer have equity interest or rights to future earnings.
Board of directors and corporate governance
Certain directors, executive officers, and employees may be considered participants in the proxy solicitation for the merger.
Updated information on directors' and officers' interests will be disclosed in the Definitive Proxy Statement.
Latest events from Kennedy-Wilson
- Merger amendment requires enhanced shareholder approval and clarifies anti-takeover provisions.KW
Proxy Filing16 Mar 2026 - Exchange offers and a management-led merger may end all stockholder equity rights if approved.KW
Proxy Filing2 Mar 2026 - Q4-25 delivered $29.6M net income, $179M adjusted EBITDA, and a pending $10.90/share buyout.KW
Q4 202525 Feb 2026 - Consortium to acquire all shares for $10.90 cash; board and key holders back deal, closing expected Q2 2026.KW
Proxy Filing17 Feb 2026 - Q2 net loss of $59.1M, but record investment management fees and strong multifamily growth.KW
Q2 20242 Feb 2026 - Adjusted EBITDA doubled, fee capital hit $8.8B, and asset sales and JV drive platform growth.KW
Q3 202415 Jan 2026 - AUM hit $28B, EBITDA tripled, and investment management fees surged in 2024.KW
Q4 202423 Dec 2025 - Resale registration of 300,000 convertible preferred shares with cumulative dividends; no proceeds to issuer.KW
Registration Filing16 Dec 2025 - Registration enables resale of convertible preferred shares with dividends and conversion rights; no proceeds to issuer.KW
Registration Filing16 Dec 2025